Clinical Trial Results Of Growth Factor Microneedling
Hair Regrowth Treatment

Country: USA
Date: August 2017-2018

Time period: 12 weeks
Company: Cellese (AnteAge)

Cellese (AnteAge) conducted a clinical trial of its 3-part combinatorial hair regrowth system, with each component
exploiting cellular signaling pathways not addressed by other products. The results of the trial proved the
efficacy of the proprietary system for stimulating hair regrowth.

👉 https://anteage-website-resources.s3.us-east-2.amazonaws.com/Whitepapers/AnteAGE+%7C+Hair+Regrowth+-+Whitepaper.pdf

______________________________________________

Low-Level Laser Therapy (LLLT) & Hair Regrowth:

National library of medicine

Research shows that LLLT devices offer a proven, safe, and effective solution for pattern hair loss in men and women, especially for individuals who haven’t seen results with other treatments.

👉https://pubmed.ncbi.nlm.nih.gov/26690359/

Low-Level Laser Therapy (LLLT) for Alopecia: A Comprehensive Review

A review of 11 studies with 680 participants found that 82% experienced significant increases in hair count and density with LLLT, highlighting its potential as an effective treatment for androgenetic alopecia.

👉https://pubmed.ncbi.nlm.nih.gov/29270707/

Low-Level Laser Therapy (LLLT) & Hair Regrowth: Evidence Based Review

A meta-analysis of seven randomised controlled trials found that LLLT had a 100% positive impact on both male and female pattern hair loss, with no reported side effects.

👉https://pubmed.ncbi.nlm.nih.gov/34546105/

Evaluation of Low-Level Laser Therapy (LLLT) Effectiveness

This comprehensive review highlights LLLT’s significant benefits across various conditions, proving it to be a powerful, non-surgical treatment option.

👉https://pubmed.ncbi.nlm.nih.gov/33425286/

______________________________________________